Table 3.

Analysis of variance “ANOVA” and low significant differences “LSD” between the effects of sub-acute pretreatment of camel milk (CM) or sub-acute dose (0.5 mg/kg) or acute dose (2.5 mg/kg) of cisplatin and pre-simultaneous treatments of CM and sub-acute dose and acute dose of cisplatin on the frequency of MN induction in bone marrow polychromatic erythrocytes (MnPCEs) of male mice.

Treatments (dose mg/kg)	Control group	ANOVA		LSD
		F	Groups	Treatment of dose	Mean difference	Sig
Sub-acute treatment (0.5 mg/kg)	I	36.56⁎⁎⁎	II	CM	−5.30
			III	Cis-DDP (0.5 mg/kg)	−62.60	⁎⁎⁎
			IV	CM → Cis-DDP	−19.30	⁎⁎
			V	CM + Cis-DDP	−39.40	⁎⁎⁎
Acute treatment (2.5 mg/kg)	I	86.90⁎⁎⁎	II	CM	−5.30
			VI	Cis-DDP (2.5 mg/kg)	−74.20	⁎⁎⁎
			VII	CM + Cis-DDP	−13.70	⁎

^⁎p < 0.05.

^⁎⁎p < 0.01.

^⁎⁎⁎p < 0.001.